Skip to main content
. 2024 Oct 22;24:407. doi: 10.1186/s12883-024-03907-6

Table 1.

Schedule of events

Procedure Screening Intervention Follow-up Frequency Duration (mins) Performed by:
Informed Consent X 1x 45 Study team
Demographics X 1x 5 Study team
Medical History X 1x 15 Study team
Physical Assessment X 1x 5 Study team
Confirmation of Eligibility X 1x 15 Study team
tDCS X 1x daily for max. 14 days 30 Study team (or trained carer)
Seizure diary X X 3x daily for max. 15 days varies Patient/carer/legal guardian
Video monitoring of seizure area (if consented) X X

1x daily 

for max. 15 days

5 Patient/carer/legal guardian
Accelerometery recordings X X 2x Continuous

Patient/legal guardian/

or study team

Adverse Event Reporting X X X Max. 15 days 20 Study team
End-of-study EEG X 1x 30 Study team

Note Administration of tDCS will end with resolution of the focal epileptic event (i.e. seizure freedom), or after 14 days, whichever happens earlier